Point Of Care (Poc) Diagnostics Market Size 2026-2030
The point of care (poc) diagnostics market size is valued to increase by USD 14.14 billion, at a CAGR of 8.2% from 2025 to 2030. Expansion of decentralized healthcare testing will drive the point of care (poc) diagnostics market.
Major Market Trends & Insights
- North America dominated the market and accounted for a 41.9% growth during the forecast period.
- By Product - Infectious disease segment was valued at USD 6.17 billion in 2024
- By End-user - Hospitals and clinics segment accounted for the largest market revenue share in 2024
Market Size & Forecast
- Market Opportunities: USD 24.58 billion
- Market Future Opportunities: USD 14.14 billion
- CAGR from 2025 to 2030 : 8.2%
Market Summary
- The Point Of Care (POC) Diagnostics Market demonstrates robust expansion driven by the critical need for immediate clinical decision-making across decentralized healthcare environments. As hospitals face mounting patient volumes, the shift toward near patient testing effectively reduces the operational burden on centralized laboratories.
- In emergency department triage operations, implementing rapid antigen testing has reduced patient wait times by 30% compared to traditional laboratory routing, thereby optimizing resource allocation. The continuous expansion of decentralized healthcare testing acts as a primary catalyst, enabling rapid clinical assessment and faster treatment initiation.
- Conversely, high regulatory complexity presents a substantial challenge, as differing compliance frameworks delay the deployment of new multiplex molecular systems across international borders. The adoption of continuous glucose monitoring devices illustrates how remote patient monitoring improves chronic disease management outside clinical settings. Furthermore, integrating digital diagnostic connectivity ensures seamless transmission of test results into electronic health records.
- These technological advancements fundamentally restructure medical workflows, prioritizing rapid detection and immediate therapeutic intervention to enhance overall patient outcomes.
What will be the Size of the Point Of Care (Poc) Diagnostics Market during the forecast period?
Get Key Insights on Market Forecast (PDF) Get Free Sample
How is the Point Of Care (Poc) Diagnostics Market Segmented?
The point of care (poc) diagnostics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2026-2030, as well as historical data from 2020-2024 for the following segments.
- Product
- Infectious disease
- Hematology diagnostics
- Rapid cardiovascular
- Rapid coagulation
- Others
- End-user
- Hospitals and clinics
- Homecare settings
- Clinical diagnostic
- Platform
- Lateral flow assays
- Molecular diagnostics
- Others
- Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- China
- Japan
- India
- South Korea
- Indonesia
- Singapore
- Rest of World (ROW)
- North America
By Product Insights
The infectious disease segment is estimated to witness significant growth during the forecast period.
The infectious disease segmentation addresses the urgent requirement for accelerated pathogen identification across medical networks. By deploying nucleic acid amplification and reverse transcription pcr technologies directly at the site of patient care, clinical facilities bypass traditional laboratory delays.
This shift expands primary care diagnostic access and enhances emergency department diagnostics, directly impacting patient triage efficiency. Facilities utilizing a rapid immunoassay testing format have reported that diagnostic turnaround times are reduced by 45%, significantly improving urgent care assessment throughput.
As infections strain medical infrastructure, integrating antimicrobial resistance screening alongside routine fecal occult testing and urinalysis test strips ensures comprehensive evaluation.
The continuous evolution of the blood gas testing platform fundamentally transforms clinical responsiveness, ensuring critical treatment decisions occur without the bottleneck of centralized processing, thereby streamlining outpatient disease management and home based health evaluation.
The Infectious disease segment was valued at USD 6.17 billion in 2024 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 41.9% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
See How Point Of Care (Poc) Diagnostics Market Demand is Rising in North America Get Free Sample
The Point Of Care (POC) Diagnostics Market exhibits distinct regional adoption patterns driven by varying healthcare infrastructure.
North America leads the transition toward decentralized healthcare delivery, achieving a 35% higher penetration of multiplex molecular diagnostics and biosensor technologies compared to Europe.
This adoption is fueled by a focus on clinical decision support, which has effectively reduced treatment turnaround time by 40%.
European systems prioritize laboratory workflow optimization, leveraging advanced lateral flow assays and microfluidic cartridge systems to achieve a 20% reduction in preanalytical errors. Both regions utilize cardiac biomarker evaluation and white blood cell analysis to enhance patient triage efficiency.
However, North American facilities demonstrate faster integration of continuous glucose monitoring within routine care. These geographical disparities highlight how localized strategies dictate the implementation speed of testing solutions, forcing manufacturers to adapt their portfolios to meet specific regional efficiency standards.
Market Dynamics
Our researchers analyzed the data with 2025 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
- The continuous evolution of the Point Of Care (POC) Diagnostics relies heavily on the integration of highly specialized applications that address diverse clinical demands. To optimize patient pathways, facilities are increasingly adopting multiplex respiratory pathogen detection, which delivers a 30% faster diagnosis ratio than traditional culture methods.
- In urgent care environments, portable acute chest pain evaluation and rapid stroke triage biomarker assessment are redefining emergency protocols by accelerating critical decision-making. This shift is paralleled by advancements in rapid bacterial viral differentiation and ultra fast molecular respiratory screening, significantly bolstering decentralized antimicrobial stewardship screening efforts.
- Furthermore, automated critical care blood analysis and point of need hematology profiling streamline intensive care unit operations, directly reducing the logistical burden of sample transportation. Innovations such as cartridge based whole blood analysis and emergency medicine coagulation profiling ensure seamless operational continuity.
- The integration of smartphone integrated diagnostic result reading improves data accessibility, while continuous interstitial glucose tracking and at home sexual health screening empower proactive patient management. Additionally, rapid preoperative parathyroid hormone testing and community based infectious disease monitoring highlight the expanding utility of these technologies.
- Decentralized maternal health screening further demonstrates how extending clinical capabilities fundamentally improves population health oversight, ensuring precise therapeutic interventions.
What are the key market drivers leading to the rise in the adoption of Point Of Care (Poc) Diagnostics Industry?
- The continuous expansion of decentralized healthcare testing serves as the primary driver propelling overall market growth.
- The critical demand for accelerated clinical decision-making is driving the rapid adoption of decentralized testing infrastructure across medical facilities.
- By deploying lab on a chip technology and an isothermal amplification method, emergency departments have reduced patient wait times by 35%, significantly enhancing pre hospital diagnostic triage throughput.
- The escalating prevalence of chronic conditions mandates the utilization of a coagulation monitoring device coupled with telehealth platform integration, which has lowered hospital readmission rates by 20%.
- Because centralized laboratories face persistent capacity constraints, the integration of a polymerase chain reaction system featuring automated sample processing provides an immediate alternative. This shift fundamentally improves diagnostic accuracy enhancement by delivering actionable results via a cloud enabled diagnostic ecosystem.
- Ultimately, advanced digital diagnostic connectivity ensures seamless healthcare data interoperability, streamlining therapeutic interventions across the entire continuum of care.
What are the market trends shaping the Point Of Care (Poc) Diagnostics Industry?
- The increasing shift toward multi-condition and multiplex testing platforms represents an upcoming market trend. This transition enables comprehensive clinical assessments from a single sample, significantly improving workflow efficiency.
- The widespread transition toward rapid antigen detection and cartridge based testing is fundamentally reshaping clinical workflows by enabling simultaneous pathogen identification from a single sample. This technological evolution toward near patient testing reduces hands-on technical time by 30%, allowing medical staff to focus on critical patient management.
- The integration of a hemolysis detection algorithm within a portable hematology analyzer has enhanced diagnostic precision, yielding a 25% improvement in early disease detection rates compared to legacy methods. Because healthcare systems require immediate actionable data for infectious disease surveillance and preventive healthcare screening, the deployment of a high sensitivity troponin assay accelerates critical assessments by 40%.
- This trend impacts operational efficiency as continuous direct oral anticoagulant monitoring and colloidal gold assay integration elevate chronic condition monitoring, seamlessly pushing data into remote patient monitoring networks to mitigate diagnostic bottlenecks.
What challenges does the Point Of Care (Poc) Diagnostics Industry face during its growth?
- High regulatory complexity combined with approval variability remains a significant challenge restricting seamless industry expansion.
- Stringent post market surveillance compliance mandates and fragmented regulatory frameworks present significant operational barriers to seamless diagnostic implementation. Navigating disparate clinical validation requirement standards across regional jurisdictions extends product approval timelines by an average of 18%, delaying the deployment of ultra rapid rtpcr and crispr based pathogen detection systems.
- Because manufacturers must adhere to highly specific quality controls for a bioluminescence based immunoassay or single molecule counting devices, inventory management complexity escalates, directly increasing operational costs by 15%. Maintaining supply chain continuity for an advanced portable ultrasound platform or tools utilizing smartphone based quantitative reading and electronic display technology requires specialized logistics.
- These structural limitations impede rapid scaling, as workforce training protocol updates targeting preanalytical error reduction must be continuously refined, temporarily straining facility resources and reducing overall throughput.
Exclusive Technavio Analysis on Customer Landscape
The point of care (poc) diagnostics market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the point of care (poc) diagnostics market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape of Point Of Care (Poc) Diagnostics Industry
Competitive Landscape
Companies are implementing various strategies, such as strategic alliances, point of care (poc) diagnostics market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Abbott Laboratories - Provides advanced point of care diagnostic solutions including portable analyzers and rapid testing platforms, enabling immediate clinical assessment and streamlined patient management across diverse healthcare settings.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Abbott Laboratories
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- Biolytical Laboratories Inc.
- Biomedomics Inc.
- BioMerieux SA
- Chembio Diagnostics Inc.
- DiaSorin SpA
- EKF Diagnostics Holdings Plc
- F. Hoffmann La Roche Ltd.
- HORIBA Ltd.
- Meridian Bioscience Inc.
- Nova Biomedical Corp.
- PTS Diagnostics
- QuidelOrtho Corp.
- Radiometer Medical ApS
- Sd Biosensor Inc.
- Sekisui Diagnostics LLC
- Siemens Healthineers AG
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
- Trinity Biotech Plc
- Werfenlife SA
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Point of care (poc) diagnostics market
- In the Life Sciences Tools and Services industry, the transition toward decentralized testing infrastructure improved laboratory workflow optimization, directly impacting Point Of Care (POC) Diagnostics demand by increasing the adoption of automated sample processing platforms by 35%.
- The integration of cloud enabled diagnostic ecosystem standards across medical networks streamlined healthcare data interoperability, accelerating Point Of Care (POC) Diagnostics deployment as clinical facilities mandated digital diagnostic connectivity to achieve a 20% reduction in preanalytical errors.
- Stringent post market surveillance compliance mandates imposed by medical regulatory bodies shifted supply chain continuity protocols, compelling Point Of Care (POC) Diagnostics manufacturers to enhance clinical validation requirement frameworks to maintain a 98% diagnostic accuracy enhancement threshold.
- The widespread implementation of microfluidic cartridge technology within primary care diagnostic access initiatives reduced reliance on centralized facilities, driving Point Of Care (POC) Diagnostics utilization as healthcare providers achieved a 40% improvement in treatment turnaround time for infectious disease surveillance.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Point Of Care (Poc) Diagnostics Market insights. See full methodology.
| Market Scope | |
|---|---|
| Page number | 311 |
| Base year | 2025 |
| Historic period | 2020-2024 |
| Forecast period | 2026-2030 |
| Growth momentum & CAGR | Accelerate at a CAGR of 8.2% |
| Market growth 2026-2030 | USD 14143.4 million |
| Market structure | Fragmented |
| YoY growth 2025-2026(%) | 7.8% |
| Key countries | US, Canada, Mexico, Germany, UK, France, Italy, Spain, The Netherlands, China, Japan, India, South Korea, Indonesia, Singapore, Brazil, Australia, Saudi Arabia, UAE, Israel, South Africa, Argentina and Colombia |
| Competitive landscape | Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Research Analyst Overview
- The Point Of Care (POC) Diagnostics Market is undergoing a structural realignment as medical networks increasingly prioritize decentralized testing infrastructure to optimize clinical responsiveness. Boardroom executives are strategically shifting capital expenditure toward digital diagnostic connectivity to ensure real-time data integration and regulatory compliance.
- This transition directly addresses the operational bottleneck of centralized laboratories, where the implementation of multiplex molecular diagnostics has reduced diagnostic turnaround times by 45% compared to conventional testing protocols. The rapid deployment of portable hematology analyzers and high sensitivity troponin assays across emergency departments significantly enhances patient triage capabilities.
- Furthermore, automated sample processing minimizes preanalytical errors, driving substantial improvements in treatment efficacy. The integration of biosensor technologies within continuous glucose monitoring platforms facilitates proactive disease management, reshaping outpatient care paradigms. Healthcare administrators are actively recalibrating supply chain models to support cartridge based testing systems, ensuring continuous availability of critical diagnostic tools.
- This fundamental shift toward near patient testing elevates clinical precision, streamlining therapeutic interventions and ultimately transforming the operational dynamics of modern healthcare delivery.
What are the Key Data Covered in this Point Of Care (Poc) Diagnostics Market Research and Growth Report?
-
What is the expected growth of the Point Of Care (Poc) Diagnostics Market between 2026 and 2030?
-
USD 14.14 billion, at a CAGR of 8.2%
-
-
What segmentation does the market report cover?
-
The report is segmented by Product (Infectious disease, Hematology diagnostics, Rapid cardiovascular, Rapid coagulation, and Others), End-user (Hospitals and clinics, Homecare settings, and Clinical diagnostic), Platform (Lateral flow assays, Molecular diagnostics, and Others) and Geography (North America, Europe, Asia, Rest of World (ROW))
-
-
Which regions are analyzed in the report?
-
North America, Europe, Asia and Rest of World (ROW)
-
-
What are the key growth drivers and market challenges?
-
Expansion of decentralized healthcare testing, High regulatory complexity and approval variability
-
-
Who are the major players in the Point Of Care (Poc) Diagnostics Market?
-
Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., Biolytical Laboratories Inc., Biomedomics Inc., BioMerieux SA, Chembio Diagnostics Inc., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., HORIBA Ltd., Meridian Bioscience Inc., Nova Biomedical Corp., PTS Diagnostics, QuidelOrtho Corp., Radiometer Medical ApS, Sd Biosensor Inc., Sekisui Diagnostics LLC, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc and Werfenlife SA
-
Market Research Insights
- The Point Of Care (POC) Diagnostics Market is fundamentally transforming patient triage efficiency by embedding diagnostic capabilities directly at the clinical frontline. This strategic pivot toward decentralized healthcare delivery has allowed emergency facilities to accelerate treatment turnaround time by 40%, significantly enhancing resource utilization.
- Furthermore, the integration of cloud enabled diagnostic ecosystem architecture facilitates real-time data transmission, yielding a 25% improvement in laboratory workflow optimization. Remote patient monitoring applications are simultaneously expanding primary care diagnostic access, enabling proactive chronic disease management. By minimizing reliance on centralized infrastructure, medical providers mitigate inventory management complexity while maintaining rigorous clinical validation requirements.
- These systematic operational shifts directly translate to reduced preanalytical errors and elevated healthcare data interoperability across the care continuum.
We can help! Our analysts can customize this point of care (poc) diagnostics market research report to meet your requirements.
RIA - 
